An implantable device to treat macular degeneration, a common cause of blindness in the elderly, has been approved by the Food and Drug Administration as safe and effective, the agency said Tuesday.
The tiny telescope made by VisionCare Ophthalmic Technologies Inc., is surgically implanted in one eye, as a replacement for the natural lens and projects an image to the healthy portion of the retina that has been magnified more than two times.
About 8 million people in the United States have age-related macular degeneration (AMD) and nearly 2 million of them already have significant vision loss, according to the National Eye Institute. AMD can make it difficult or impossible to recognize faces or perform daily tasks such as reading or watching television.




























